Literature DB >> 7833226

Adenosine modulation of neurotransmission in penile erection.

P H Chiang1, S N Wu, E M Tsai, C C Wu, M R Shen, C H Huang, C P Chiang.   

Abstract

1. Adenosine inhibited the noradrenaline-induced contraction of rabbit corpus cavernosum in a dose-dependent manner. The effect of adenosine was greater in intact corpus cavernosa than in endothelium-denuded preparations. This finding indicates that the relaxing effect of adenosine is partially endothelium-dependent and involved in the release of endothelium-derived relaxing factors. 2. Adenosine and its analogues relaxed the noradrenaline-induced contractile response as well as inhibited the transmural nerve induced contraction with the potency order: NECA > R-PIA > adenosine. These data indicate that adenosine can modulate both the non-adrenergic non-cholinergic and adrenergic neurotransmission. DMPX, an adenosine antagonist selective for the A2 receptors, abolished the electrically elicited relaxation. However, CGS 21680, selective for A2a receptor, had no effect on relaxation. Therefore, adenosine receptors involved in the modulation of neurotransmission in rabbit corpus cavernosum appear to be A2b subtype. 3. Adenosine also induced an increase in human cavernosal arterial velocity and resistive index measured by colour duplex sonography. The combination of adenosine and 10 micrograms prostaglandin E1 was more effective in resistive index and erection grade than 20 micrograms prostaglandin E1 alone. Our results suggest that adenosine seems to be an important neuromodulator for penile erection and can be an effective and alternative combination in the treatment of impotence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833226      PMCID: PMC1364780          DOI: 10.1111/j.1365-2125.1994.tb04366.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

Review 1.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

Review 2.  Adenosine receptors: targets for future drugs.

Authors:  J W Daly
Journal:  J Med Chem       Date:  1982-03       Impact factor: 7.446

3.  Adenosine modulation of adrenergic neurotransmission in the human fallopian tube.

Authors:  N P Wiklund; U E Samuelson; J Brundin
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

4.  Adenosine-modulation of cholinergic and non-adrenergic non-cholinergic neurotransmission in the rabbit iris sphincter.

Authors:  L E Gustafsson; N P Wiklund
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

5.  Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.

Authors:  G Richardt; W Waas; R Kranzhöfer; E Mayer; A Schömig
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

6.  Endothelium-dependent relaxation of the pig aorta: relationship to stimulation of 86Rb efflux from isolated endothelial cells.

Authors:  J L Gordon; W Martin
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

7.  Neuropeptide Y in the human male genital tract.

Authors:  T E Adrian; J Gu; J M Allen; K Tatemoto; J M Polak; S R Bloom
Journal:  Life Sci       Date:  1984-12-24       Impact factor: 5.037

8.  Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking.

Authors:  W W Barrington; K A Jacobson; A J Hutchison; M Williams; G L Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Adenosine selectively inhibits noncholinergic transmission in guinea pig bronchi.

Authors:  Y Kamikawa; Y Shimo
Journal:  J Appl Physiol (1985)       Date:  1989-05

10.  A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis.

Authors:  C G Stief; F Benard; R J Bosch; S R Aboseif; T F Lue; E A Tanagho
Journal:  J Urol       Date:  1990-02       Impact factor: 7.450

View more
  17 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

Review 3.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 4.  Role of adenosine signaling in penile erection and erectile disorders.

Authors:  Prasad V Phatarpekar; Jiaming Wen; Yang Xia
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

5.  Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.

Authors:  Hayamitsu Adachi; Krishnan K Palaniappan; Andrei A Ivanov; Nathaniel Bergman; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-03-23       Impact factor: 7.446

6.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

7.  Chronic treatment with cyclosporine A in New Zealand rabbit: aortic and erectile tissue alterations.

Authors:  E Ragazzi; C Meggiato; A Chinellato; G Italiano; F Pagano; A Calabrò
Journal:  Urol Res       Date:  1996

8.  Characterization of in vitro relaxant mechanisms in erectile tissue from rabbits of different ages.

Authors:  E Ragazzi; A Chinellato; G Italiano; F Pagano; A Calabrò
Journal:  Urol Res       Date:  1996

9.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.